Financial Overview - FTAI Infrastructure reported a net income attributable to stockholders of $109.724 million for Q1 2025, compared to a net loss of $56.582 million in Q1 2024, marking a significant turnaround [2][14] - Basic earnings per share (EPS) for common stock was $0.95, while diluted EPS was $0.89 [2][14] - Adjusted EBITDA for the quarter was $155.219 million, with the four core segments contributing $164.512 million [2][21] Revenue and Expenses - Total revenues for Q1 2025 were $96.161 million, an increase from $82.535 million in Q1 2024 [13] - Operating expenses rose to $67.045 million from $64.575 million year-over-year [13] - Total expenses increased to $104.602 million from $93.884 million in the previous year [13] Dividends - The Board of Directors declared a cash dividend of $0.03 per share for the quarter ended March 31, 2025, payable on May 27, 2025 [4] Business Highlights - The company completed refinancing and increased ownership at Long Ridge, executed new contracts and letters of intent at Repauno, and commenced the first of three contracts at Jefferson on April 1, 2025 [9][10] Cash Flow - The net cash used in operating activities was $85.651 million, while net cash provided by investing activities was $164.299 million [19] - The company reported a net increase in cash and cash equivalents and restricted cash of $76.111 million, ending the period with $223.407 million [19] Balance Sheet - Total assets as of March 31, 2025, were $4.142 billion, up from $2.374 billion at the end of 2024 [16][17] - Total liabilities increased to $3.275 billion from $1.918 billion [17] Key Performance Measures - Adjusted EBITDA is utilized as a key performance measure, providing insights into operational performance and resource allocation decisions [21][22]

Delivers resilient recurring revenue performance and sustained margin expansion in Q1 2025; accelerates pace of share buyback TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Altus Group Limited ("Altus Group" or "the Company") (TSX: AIF), a leading provider of commercial real estate ("CRE") intelligence, announced today its financial and operating results for the first quarter ended March 31, 2025. "Our strong performance in Q1 demonstrates the continued execution of our growth initiatives and our commitment to d ...

FORT WORTH, Texas, May 8, 2025 /PRNewswire/ -- PHX MINERALS INC., "PHX" or the "Company" (NYSE: PHX), today reported financial and operating results for the quarter ended March 31, 2025.Summary of Results for the Quarter Ended March 31, 2025 Net income was $4.4 million, or $0.12 per diluted share, compared to net income of $0.1 million, or $0.00 per diluted share, for the quarter ended Dec. 31, 2024, and net loss of ($0.2) million, or ($0.01) per diluted share, for the quarter ended March 31, 2024. Adjusted ...

Core Insights - GrowGeneration Corp. reported a first quarter net sales of $35.7 million, a decrease from $47.9 million in the same period last year, primarily due to the closure of 19 retail locations in 2024 [4][6] - Proprietary brand sales increased to 32.0% of total Cultivation and Gardening revenue, up from 22.6% year-over-year, reflecting the strength of the company's product portfolio [5][6] - The gross profit margin improved to 27.2%, compared to 25.8% in the first quarter of 2024, indicating operational efficiency [7][9] Financial Performance - The company reported a net loss of $9.4 million for the first quarter of 2025, compared to a net loss of $8.8 million in the same quarter of 2024 [9][10] - Adjusted EBITDA loss was $4.0 million, worsening from a loss of $2.9 million in the prior year [10][26] - Cash, cash equivalents, and marketable securities totaled $52.6 million with no debt, providing financial flexibility for future growth initiatives [6][10] Operational Strategy - The company is transitioning to a regional fulfillment center model and focusing on B2B engagement, moving away from same-store sales as a key performance metric [3][12] - Store and other operating expenses decreased by approximately 17.3% to $8.8 million compared to $10.6 million in the first quarter of 2024 [8][9] - The company has withdrawn its full-year 2025 financial outlook due to macroeconomic uncertainties and is exploring strategies to mitigate risks [12] Future Outlook - For the second quarter of 2025, GrowGeneration expects total consolidated net sales to exceed $40 million [13]

WEST FARGO, N.D., May 08, 2025 (GLOBE NEWSWIRE) -- Titan Machinery Inc. (Nasdaq: TITN), a leading network of full-service agricultural and construction equipment stores, announced today it will release financial results for the first quarter April 30, 2025, on Thursday, May 22, 2025, followed by an investor conference call at 7:30 a.m. Central time (8:30 a.m. Eastern time). Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. International callers can dial (201) 389-0 ...

PONTE VEDRA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today reported financial results for the first quarter ended March 31, 2025. Recent Highlights Generated revenue of $52.6 million in first quarter 2025 representing growth of 3% over the same pe ...

Core Insights - Crinetics Pharmaceuticals is on track for the FDA review of paltusotine, with a PDUFA date set for September 25, 2025, for the treatment of acromegaly [5][6] - The company is initiating a Phase 3 study for atumelnant aimed at normalizing androstenedione levels in adults with congenital adrenal hyperplasia (CAH) [3][6] - Crinetics has a strong financial position with $1.3 billion in cash and equivalents as of March 31, 2025, expected to fund operations into 2029 [10][14] Regulatory and Clinical Developments - The FDA review process for paltusotine's New Drug Application (NDA) is progressing positively, with consistent engagement from the FDA [6] - The European Medicines Agency (EMA) has validated the marketing authorization application (MAA) for paltusotine, with a potential decision expected in the first half of 2026 [6] - The Phase 2 TouCAHn study of atumelnant in CAH has shown positive results, leading to the initiation of a Phase 3 CALM-CAH study [6][10] Financial Performance - Revenues for the first quarter of 2025 were $0.4 million, down from $0.6 million in the same period of 2024, primarily from a licensing agreement for paltusotine [10][14] - Research and development expenses increased to $76.2 million in Q1 2025 from $53.3 million in Q1 2024, driven by clinical program advancements [10][14] - The net loss for Q1 2025 was $96.8 million, compared to a net loss of $66.9 million in Q1 2024 [10][14] Upcoming Milestones - R&D Day is scheduled for June 26, 2025, to discuss early-stage pipeline strategies and data [3][10] - The company plans to initiate the CAREFNDR Phase 3 trial of paltusotine in carcinoid syndrome in the second half of 2025 [10] - Initiation of the CALM-CAH Phase 3 study in adults and a Phase 2/3 study in pediatrics is expected in the second half of 2025 [10]

Core Insights - Rumble Inc. reported a revenue increase of 34% year-over-year, reaching $23.7 million for Q1 2025, driven by higher subscription revenue and monetization efforts [1][4][5] - The company achieved improved monthly active user (MAU) retention of 87% post the 2024 U.S. general election, compared to 60% retention after the 2022 midterm elections [1][4] - Rumble's net loss for Q1 2025 was $2.7 million, a significant improvement from a loss of $43.3 million in Q1 2024 [1][4][5] Financial Performance - Revenue for Q1 2025 was $23.7 million, up from $17.7 million in Q1 2024, marking a $6.0 million increase [4][6] - Average Revenue Per User (ARPU) decreased by 13% to $0.34 compared to Q4 2024, attributed to lower advertising revenue [4][6] - Adjusted EBITDA loss improved to $22.7 million in Q1 2025 from a loss of $26.5 million in Q1 2024 [4][28] User Engagement - Average global MAUs were 59 million in Q1 2025, down from 68 million in Q4 2024, reflecting a decrease in user engagement [4][5] - The company noted that the decline in MAUs was offset by improved retention rates following the U.S. elections [4][5] Cost Structure - Total expenses for Q1 2025 were $60.1 million, an increase from $52.7 million in Q1 2024, with general and administrative expenses rising significantly by 78% [6][8] - Cost of services decreased by 6% to $30.0 million, primarily due to reduced programming and content costs [6][7] Strategic Developments - Rumble Cloud secured a contract with the Government of El Salvador, indicating a strategic move towards government partnerships [1][4] - The company announced a partnership with the Tampa Bay Buccaneers, expanding its presence in the sports sector [1][4][5] Balance Sheet and Liquidity - As of March 31, 2025, Rumble had total liquidity of $318.7 million, including $301.3 million in cash and cash equivalents [4][6] - The company completed a Tether investment, which has solidified its balance sheet [1][4][5]

RONKONKOMA, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- SUNation Energy, Inc. (Nasdaq: SUNE) (“SUNation” or “the Company”), a leading provider of sustainable solar energy and backup power solutions for households, businesses, and municipalities, today announced that it will issue its financial results for the first quarter ended March 31, 2025 on Thursday, May 15, 2025 after the close of the stock market. The Company will host a corresponding conference call on Friday, May 16, 2025 at 9:00 a.m. ET, to discuss th ...

Company to Host Conference Call on Thursday, May 8, 2025, at 2:30 p.m. PT/5:30 p.m. ETALHAMBRA, Calif., May 8, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the first quarter ended March 31, 2025."Astrana's s ...